Anez C. Ebrahim

Array ( [id] => 3487536 [patent_doc_number] => 05426098 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-06-20 [patent_title] => 'Increase in hematopoietic progenitor cells in peripheral blood by transforming growth factor beta' [patent_app_type] => 1 [patent_app_number] => 8/116253 [patent_app_country] => US [patent_app_date] => 1993-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3500 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/426/05426098.pdf [firstpage_image] =>[orig_patent_app_number] => 116253 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3002890 [patent_doc_number] => 05371196 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-12-06 [patent_title] => 'Process for producing secretory immunoglobulin A preparations' [patent_app_type] => 1 [patent_app_number] => 8/115458 [patent_app_country] => US [patent_app_date] => 1993-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5860 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 123 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/371/05371196.pdf [firstpage_image] =>[orig_patent_app_number] => 115458 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3417076 [patent_doc_number] => 05453420 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-09-26 [patent_title] => 'Food preservative and production thereof' [patent_app_type] => 1 [patent_app_number] => 8/109315 [patent_app_country] => US [patent_app_date] => 1993-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2016 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/453/05453420.pdf [firstpage_image] =>[orig_patent_app_number] => 109315 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3473122 [patent_doc_number] => 05431909 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-07-11 [patent_title] => 'Stabilization of human interferon' [patent_app_type] => 1 [patent_app_number] => 8/105923 [patent_app_country] => US [patent_app_date] => 1993-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 7 [patent_no_of_words] => 8790 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/431/05431909.pdf [firstpage_image] =>[orig_patent_app_number] => 105923 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3589439 [patent_doc_number] => 05585348 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-17 [patent_title] => 'Use of excitatory opioid receptor antagonists to prevent growth factor-induced hyperalgesia' [patent_app_type] => 1 [patent_app_number] => 8/106401 [patent_app_country] => US [patent_app_date] => 1993-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 5373 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/585/05585348.pdf [firstpage_image] =>[orig_patent_app_number] => 106401 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3005394 [patent_doc_number] => 05374624 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-12-20 [patent_title] => 'Fluorocarbon blood substitute' [patent_app_type] => 1 [patent_app_number] => 8/105770 [patent_app_country] => US [patent_app_date] => 1993-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6067 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/374/05374624.pdf [firstpage_image] =>[orig_patent_app_number] => 105770 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3591274 [patent_doc_number] => 05585467 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-17 [patent_title] => 'Proteoglycan(G009) effective in enhancing antitumor immunity' [patent_app_type] => 1 [patent_app_number] => 8/066162 [patent_app_country] => US [patent_app_date] => 1993-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 6196 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/585/05585467.pdf [firstpage_image] =>[orig_patent_app_number] => 066162 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3456445 [patent_doc_number] => 05378811 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-01-03 [patent_title] => 'Pure C3b inactivator and a process for producing said protein' [patent_app_type] => 1 [patent_app_number] => 8/089905 [patent_app_country] => US [patent_app_date] => 1993-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2821 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/378/05378811.pdf [firstpage_image] =>[orig_patent_app_number] => 089905 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3414585 [patent_doc_number] => 05444158 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-08-22 [patent_title] => 'Merosin, nucleic acids encoding, fragments and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/087642 [patent_app_country] => US [patent_app_date] => 1993-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 33 [patent_no_of_words] => 10452 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/444/05444158.pdf [firstpage_image] =>[orig_patent_app_number] => 087642 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3475080 [patent_doc_number] => 05428012 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-06-27 [patent_title] => 'Oncostatin M and novel compositions having anti-neoplastic activity' [patent_app_type] => 1 [patent_app_number] => 8/085279 [patent_app_country] => US [patent_app_date] => 1993-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 11 [patent_no_of_words] => 19405 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/428/05428012.pdf [firstpage_image] =>[orig_patent_app_number] => 085279 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3715516 [patent_doc_number] => 05616558 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-01 [patent_title] => 'Medicaments comprising glicentin as active ingredient' [patent_app_type] => 1 [patent_app_number] => 8/083501 [patent_app_country] => US [patent_app_date] => 1993-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2998 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/616/05616558.pdf [firstpage_image] =>[orig_patent_app_number] => 083501 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3462954 [patent_doc_number] => 05391713 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-02-21 [patent_title] => 'Interferon purification process' [patent_app_type] => 1 [patent_app_number] => 8/066655 [patent_app_country] => US [patent_app_date] => 1993-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2619 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/391/05391713.pdf [firstpage_image] =>[orig_patent_app_number] => 066655 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3461082 [patent_doc_number] => 05382655 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-01-17 [patent_title] => 'Process for the purification of cyclosporin A' [patent_app_type] => 1 [patent_app_number] => 8/066857 [patent_app_country] => US [patent_app_date] => 1993-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3456 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/382/05382655.pdf [firstpage_image] =>[orig_patent_app_number] => 066857 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3441574 [patent_doc_number] => 05430017 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-07-04 [patent_title] => 'Oral pharmaceutical composition containing cyclosporin and process for preparing same' [patent_app_type] => 1 [patent_app_number] => 7/915719 [patent_app_country] => US [patent_app_date] => 1993-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2749 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/430/05430017.pdf [firstpage_image] =>[orig_patent_app_number] => 915719 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2997543 [patent_doc_number] => 05362855 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-11-08 [patent_title] => 'Imidoester cross-linked hemoglobin compositions' [patent_app_type] => 1 [patent_app_number] => 8/065170 [patent_app_country] => US [patent_app_date] => 1993-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7796 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/362/05362855.pdf [firstpage_image] =>[orig_patent_app_number] => 065170 [rel_patent_id] =>[rel_patent_doc_number] =>)